跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack
Approved
STANDARD
MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack
ORGANON PHARMA PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a2ba2e2e3f240b48
Company
ORGANON PHARMA PTY LTD
Type
Standard
Approval Details
Approval Id
a2ba2e2e3f240b48
Product Name
MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack
Artg Id
407853
Artg Name
MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack
Sponsor
ORGANON PHARMA PTY LTD
Company Detail Path
/organization/organon-pharma-pty-ltd
Artg Date
2023-04-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/857350d715fb63eb6c073bc95426b45a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ef15da358af13b79424571f672ee75e7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a2ba2e2e3f240b48
Type
Standard
Back to TGA Approvals